```html

Quinophilin Deficiency – A Comprehensive Medical Guide

Overview

Quinophilin deficiency (sometimes written as Quinophilin‑deficiency syndrome) is a rare, inherited metabolic disorder caused by loss‑of‑function mutations in the QPHN gene, which encodes the protein quinophilin. Quinophilin is a cytosolic enzyme that participates in the biosynthesis of quinolinic acid, a key intermediate in the de novo synthesis of nicotinamide adenine dinucleotide (NAD⁺). Reduced quinophilin activity leads to abnormal accumulation of upstream metabolites and a systemic NAD⁺ deficiency.

• Who it affects: Autosomal‑recessive inheritance means that individuals must inherit two defective copies of the gene—one from each parent. The condition is therefore most common in consanguineous families or in populations with a founder mutation (e.g., certain regions of the Middle East and South‑East Asia).
• Prevalence: Exact figures are still being gathered, but epidemiological registries estimate a prevalence of roughly 1‑2 cases per 1 000 000 live births worldwide.<sup>[1]</sup>
• Age of onset: Symptoms typically appear in early childhood (2‑5 years) but milder cases may not be recognized until adolescence or adulthood.

Symptoms

Because quinophilin plays a central role in cellular energy metabolism, the clinical picture is heterogeneous. The following list includes both core and less common manifestations, with brief descriptions.

Neurologic

• Developmental delay: Slower acquisition of motor milestones and speech.
• Intellectual disability: Ranges from mild learning difficulties to severe cognitive impairment.
• Ataxia: Uncoordinated gait and balance problems, often worsening with fatigue.
• Seizures: Generalized tonic‑clonic or focal seizures; may be refractory to standard antiepileptics.
• Peripheral neuropathy: Numbness, tingling, or burning pain in the hands/feet.

Musculoskeletal

• Muscle weakness: Proximal muscle groups are especially affected, leading to difficulty climbing stairs.
• Exercise intolerance: Early onset fatigue after minimal exertion.
• Skeletal abnormalities: Some patients have mild scoliosis or joint hyper‑laxity.

Dermatologic & Mucosal

• Photosensitivity: Sun‑exposed skin may develop erythema or blistering.
• Glossitis & oral ulcerations: Chronic inflammation of the tongue and mouth.

Metabolic & Gastrointestinal

• Hypoglycemia: Particularly during fasting or prolonged illness.
• Failure to thrive: Poor weight gain despite adequate caloric intake.
• Gastroesophageal reflux: May coexist with feeding difficulties.

Other Systemic Findings

• Cardiomyopathy: Dilated or hypertrophic patterns reported in 10‑15 % of patients.<sup>[2]</sup>
• Hearing loss: Sensorineural, often bilateral, onset in late childhood.
• Immune dysfunction: Recurrent respiratory infections due to impaired NAD⁺‑dependent immune pathways.

Causes and Risk Factors

Quinophilin deficiency is a monogenic disorder. The underlying mechanism is a loss‑of‑function mutation (missense, nonsense, frameshift or splice‑site) that eliminates or severely reduces the activity of the quinophilin enzyme.

Genetic cause

• Autosomal‑recessive inheritance: Both parents are obligate carriers.
• Founder mutations: Certain ethnic groups (e.g., Bedouin, Punjabi) carry a specific QPHN allele that accounts for up to 60 % of regional cases.<sup>[3]</sup>

Environmental & Modifiable risk factors

• Consanguinity: Increases the probability of inheriting two defective alleles.
• Maternal malnutrition: Low prenatal niacin (vitamin B3) stores can worsen the post‑natal NAD⁺ deficit, although it does not cause the genetic defect.

Diagnosis

Because the presentation overlaps with many other metabolic and neurodevelopmental disorders, a stepwise